|
Originally published In Press as doi:10.1074/jbc.M111842200 on February 4, 2002
J. Biol. Chem., Vol. 277, Issue 17, 14933-14941, April 26, 2002
MICAL, a Novel CasL Interacting Molecule, Associates with
Vimentin*
Takahiro
Suzuki ,
Tetsuya
Nakamoto ,
Seishi
Ogawa ,
Sachiko
Seo ,
Tomoko
Matsumura ,
Kouichi
Tachibana§,
Chikao
Morimoto¶, and
Hisamaru
Hirai
From the Department of Hematology and Oncology,
Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo,
Bunkyo-ku, Tokyo, 113-8655, the § Laboratory of Gene
Function Analysis, Institute of Molecular and Cell Biology, National
Institute of Advanced Industrial Science and Technology, Central-2
OSL-C2, 1-1-1 Umezono, Tsukuba, Ibaraki 305-8568, and the
¶ Department of Clinical Immunology and AIDS Research Center,
Institute of Medical Science, University of Tokyo, 4-6-1 Shiroganedai,
Minato-ku, Tokyo 108-8639, Japan
CasL/HEF1 belongs to the
p130Cas family. It is tyrosine-phosphorylated
following 1 integrin and/or T cell receptor stimulation and is thus considered to be important for immunological reactions. CasL has several structural motifs such as an SH3 domain and a substrate domain and interacts with many molecules through these motifs. To obtain more insights on the CasL-mediated signal
transduction, we sought proteins that interact with the CasL SH3 domain
by far Western screening, and we identified a novel human molecule,
MICAL (a Molecule Interacting with
CasL). MICAL is a protein of 118 kDa and is
expressed in the thymus, lung, spleen, kidney, testis, and
hematopoietic cells. MICAL has a calponin homology domain, a LIM
domain, a putative leucine zipper motif, and a proline-rich PPKPP
sequence. MICAL associates with CasL through this PPKPP sequence. MICAL is a cytoplasmic protein and colocalizes with CasL at
the perinuclear area. Through the COOH-terminal region, MICAL also
associates with vimentin that is a major component of intermediate
filaments. Immunostaining revealed that MICAL localizes along with
vimentin intermediate filaments. These results suggest that MICAL may
be a cytoskeletal regulator that connects CasL to intermediate filaments.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AB048948.
To whom correspondence should be addressed: Dept. of
Hematology and Oncology, Graduate School of Medicine, University of
Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. Tel.:
81-3-5800-6421; Fax: 81-3-5689-7286; E-mail:
hhirai-tky@umin.ac.jp.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Ishida, M. A. Borman, J. Ostrander, H. J. Vogel, and J. A. MacDonald
Solution Structure of the Calponin Homology (CH) Domain from the Smoothelin-like 1 Protein: A UNIQUE APOCALMODULIN-BINDING MODE AND THE POSSIBLE ROLE OF THE C-TERMINAL TYPE-2 CH-DOMAIN IN SMOOTH MUSCLE RELAXATION
J. Biol. Chem.,
July 18, 2008;
283(29):
20569 - 20578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fukuda, E. Kanno, K. Ishibashi, and T. Itoh
Large Scale Screening for Novel Rab Effectors Reveals Unexpected Broad Rab Binding Specificity
Mol. Cell. Proteomics,
June 1, 2008;
7(6):
1031 - 1042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nakatsuji, N. Nishimura, R. Yamamura, H.-o. Kanayama, and T. Sasaki
Involvement of Actinin-4 in the Recruitment of JRAB/MICAL-L2 to Cell-Cell Junctions and the Formation of Functional Tight Junctions
Mol. Cell. Biol.,
May 15, 2008;
28(10):
3324 - 3335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Yamamura, N. Nishimura, H. Nakatsuji, S. Arase, and T. Sasaki
The Interaction of JRAB/MICAL-L2 with Rab8 and Rab13 Coordinates the Assembly of Tight Junctions and Adherens Junctions
Mol. Biol. Cell,
March 1, 2008;
19(3):
971 - 983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. F. Schmidt, S.-O. Shim, and S. M. Strittmatter
Release of MICAL Autoinhibition by Semaphorin-Plexin Signaling Promotes Interaction with Collapsin Response Mediator Protein
J. Neurosci.,
February 27, 2008;
28(9):
2287 - 2297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Huang, U. Yazdani, K. L. Thompson-Peer, A. L. Kolodkin, and J. R. Terman
Crk-associated substrate (Cas) signaling protein functions with integrins to specify axon guidance during development
Development,
June 15, 2007;
134(12):
2337 - 2347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Lepelletier, S. Smaniotto, R. Hadj-Slimane, D. M. S. Villa-Verde, A. C. Nogueira, M. Dardenne, O. Hermine, and W. Savino
Control of human thymocyte migration by Neuropilin-1/Semaphorin-3A-mediated interactions
PNAS,
March 27, 2007;
104(13):
5545 - 5550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hochman, A. Castiel, J. Jacob-Hirsch, N. Amariglio, and S. Izraeli
Molecular Pathways Regulating Pro-migratory Effects of Hedgehog Signaling
J. Biol. Chem.,
November 10, 2006;
281(45):
33860 - 33870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Pasterkamp and J. Verhaagen
Semaphorins in axon regeneration: developmental guidance molecules gone wrong?
Phil Trans R Soc B,
September 29, 2006;
361(1473):
1499 - 1511.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Viemann, M. Goebeler, S. Schmid, U. Nordhues, K. Klimmek, C. Sorg, and J. Roth
TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells
J. Leukoc. Biol.,
July 1, 2006;
80(1):
174 - 185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Togashi, E. F. Schmidt, and S. M. Strittmatter
RanBPM contributes to Semaphorin3A signaling through plexin-A receptors.
J. Neurosci.,
May 3, 2006;
26(18):
4961 - 4969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ashida, M. Furihata, T. Katagiri, K. Tamura, Y. Anazawa, H. Yoshioka, T. Miki, T. Fujioka, T. Shuin, Y. Nakamura, et al.
Expression of Novel Molecules, MICAL2-PV (MICAL2 Prostate Cancer Variants), Increases with High Gleason Score and Prostate Cancer Progression.
Clin. Cancer Res.,
May 1, 2006;
12(9):
2767 - 2773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Terai, N. Nishimura, I. Kanda, N. Yasui, and T. Sasaki
JRAB/MICAL-L2 Is a Junctional Rab13-binding Protein Mediating the Endocytic Recycling of Occludin
Mol. Biol. Cell,
May 1, 2006;
17(5):
2465 - 2475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nadella, M. A. Bianchet, S. B. Gabelli, J. Barrila, and L. M. Amzel
Structure and activity of the axon guidance protein MICAL
PNAS,
November 15, 2005;
102(46):
16830 - 16835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Siebold, N. Berrow, T. S. Walter, K. Harlos, R. J. Owens, D. I. Stuart, J. R. Terman, A. L. Kolodkin, R. J. Pasterkamp, and E. Y. Jones
High-resolution structure of the catalytic region of MICAL (molecule interacting with CasL), a multidomain flavoenzyme-signaling molecule
PNAS,
November 15, 2005;
102(46):
16836 - 16841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kanapin, S. Batalov, M. J. Davis, J. Gough, S. Grimmond, H. Kawaji, M. Magrane, H. Matsuda, C. Schonbach, R. D. Teasdale, et al.
Mouse Proteome Analysis
Genome Res.,
June 1, 2003;
13(6):
1335 - 1344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ventura and P. G. Pelicci
Semaphorins: Green Light for Redox Signaling?
Sci. Signal.,
October 22, 2002;
2002(155):
pe44 - pe44.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|